Tevogen Bio Holdings - Warrants (14/02/2029) Operating Income

The latest operating income for TVGNW is $-21M as of June 2026. That compares with $-31M in the prior-year period — up 31.5% year over year. Investors often review this figure alongside Tevogen Bio Holdings - Warrants (14/02/2029)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, TVGNW's operating income moved from $-31M to $-21M — a 31.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Tevogen Bio Holdings - Warrants (14/02/2029)'s operating scale or balance-sheet position.

A operating income figure of $-21M for TVGNW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting TVGNW's operating income ($-21M), review year-over-year change from $-31M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.